Cargando…
Efficacy and Safety of Jinshuibao Capsule in Diabetic Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
OBJECTIVE: This systematic review was able to evaluate the clinical evidence of JSBC in the randomized controlled trial (RCT) of diabetic nephropathy. METHODS: The Chinese and English literatures published in PubMed, Cochrane Library, VIP, Wanfang Data, CNKI, and CBM before July 30, 2019, were retri...
Autores principales: | Yu, Xinyu, Yan, Dongmei, Lan, Qin, Fang, Jianhe, Ding, Zhaohui, Guan, Yongmei, Zhu, Weifeng, Yan, Lei, Nie, Heyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441367/ https://www.ncbi.nlm.nih.gov/pubmed/36072775 http://dx.doi.org/10.1155/2022/9671768 |
Ejemplares similares
-
Clinical Efficacy of Jinshuibao Capsules Combined with Angiotensin Receptor Blockers in Patients with Early Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials
por: Lu, Qiang, et al.
Publicado: (2018) -
Effects of Shenkang Injection Combined with Jinshuibao on Early Diabetic Nephropathy and Effects on Coagulation Fibrinolysis System and Urinary Protein
por: Zhu, Jianhua, et al.
Publicado: (2022) -
Efficacy of Jinshuibao as an adjuvant treatment for chronic renal failure in China: A meta-analysis
por: Zhang, Huan, et al.
Publicado: (2023) -
Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats
por: Zhang, Lei, et al.
Publicado: (2020) -
Efficacy and safety of Hou Gu Mi Xi for peptic ulcer diseases: Study protocol for a randomized controlled trial
por: Chen, Xiaofan, et al.
Publicado: (2019)